Arthritis Res Ther

Correction: Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome.

Notarnicola A, Preger C, Lundström SL, ..., Lundberg IE, Fernandes-Cerqueira C

Arthritis Res Ther 26 (1) 206 [2024-12-02; online 2024-12-02]

Methotrexate promotes the release of granulocyte-macrophage colony-stimulating factor from rheumatoid arthritis fibroblast-like synoviocytes via autocrine interleukin-1 signaling.

Bergström B, Selldén T, Bollmann M, Svensson MND, Ekwall AH

Arthritis Res Ther 26 (1) 178 [2024-10-11; online 2024-10-11]

Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome.

Notarnicola A, Preger C, Lundström SL, ..., Lundberg IE, Fernandes-Cerqueira C

Arthritis Res Ther 24 (1) 62 [2022-03-02; online 2022-03-02]

Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.

Idborg H, Zandian A, Sandberg AS, ..., Svenungsson E, Jakobsson PJ

Arthritis Res Ther 21 (1) 62 [2019-02-18; online 2019-02-18]

Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor.

Hjorton K, Hagberg N, Israelsson E, ..., Eloranta ML, Rönnblom L

Arthritis Res Ther 20 (1) 238 [2018-10-24; online 2018-10-24]